Organigram Share Price (NASDAQ: OGI)

$1.69

▲

0.04

(2.42%)

Live

Last updated on August 28, 2025 at 12:43 am IST

$₹

Check the interactive Organigram Stock chart to analyse performance

Organigram stock performance

as on August 28, 2025 at 12:43 am IST

Today's Low:$1.63
Today's High:$1.69
$1.69
3.55%
Downside
Day's Volatility :3.55%
Upside
0.0%
52 Weeks Low:$0.85
52 Weeks High:$2.00
$1.69
49.7%
Downside
52 Weeks Volatility :57.5%
Upside
15.5%

Organigram Stock Returns

Period	Organigram Holdings Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	22.22%	3.7%	0.0%
6 Months	42.24%	-6.9%	0.0%
1 Year	-9.84%	-11.9%	0.0%
3 Years	-62.84%	7.7%	-6.9%

Organigram Holdings Inc Key Stats

Check Organigram key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.65
Open	$1.64
Today's High	$1.69
Today's Low	$1.63
Market Capitalization	$218.5M
Today's Volume	$934.6K
52 Week High	$2.0
52 Week Low	$0.85
Revenue TTM	$223.8M
EBITDA	$-2.2M
Earnings Per Share (EPS)	$0.01
PE Ratio	163.0
Profit Margin	3.47%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-54.53%

Stock Returns calculator for Organigram Stock including INR - Dollar returns

The Organigram stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Organigram investment value today

Current value as on today

₹97,023

Returns

₹2,977

(-2.98%)

Returns from Organigram Stock

₹7,650 (-7.65%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Organigram Stock

43%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Organigram Stock from India on INDmoney has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Organigram Holdings Inc

Name
Holdings %
Name
Holdings %
AdvisorShares Investments, LLC
0.60%
Dimensional Fund Advisors, Inc.
0.18%
Goldman Sachs Group Inc
0.11%
The Toronto-Dominion Bank
0.07%
Mariner Wealth Advisors LLC
0.05%
Vontobel Holding Ltd.
0.05%

Analyst Recommendation on Organigram Stock

Rating

Trend

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Organigram(by analysts ranked 0 to 5 stars)

Organigram Share Price Target

What analysts predicted

Upside of 420.71%

Target:

$8.80

Current:

$1.69

Organigram share price target is $8.80, a slight Upside of 420.71% compared to current price of $1.69 as per analysts' prediction.

Organigram Stock Insights

Price Movement
In the last 7 days, OGI stock has moved up by 10.0%
Increasing Revenue
Revenue is up for the last 3 quarters, 42.73M → 70.79M (in $), with an average increase of 21.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 42.45M → -6.29M (in $), with an average decrease of 114.8% per quarter
OGI vs HLN (1 yr)
In the last 1 year, Organigram Holdings Inc has experienced a drawdown of -9.8%, however Haleon Plc Spon Ads resisted the overall trend and outperformed by 6.3%
OGI vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 54.5% return, outperforming this stock by 116.7%
Price to Sales
ForOGI every $1 of sales, investors are willing to pay $0.8, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Organigram Holdings Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY21

FY22

FY23

FY24

	FY21	Y/Y Change
Revenue	$62.5M	↑ 0.0%
Net Income	$-103.2M	↓ 1.39%
Net Profit Margin	-165.11%	↑ 2.32%

	FY22	Y/Y Change
Revenue	$109.7M	↑ 0.0%
Net Income	$-10.7M	↑ 0.0%
Net Profit Margin	-9.8%	↑ 0.0%

	FY22	Y/Y Change
Revenue	$109.7M	↑ 0.0%
Net Income	$-10.7M	↑ 0.0%
Net Profit Margin	-9.8%	↑ 0.0%

	FY23	Y/Y Change
Revenue	$110.1M	↑ 0.0%
Net Income	$-169.4M	↑ 0.0%
Net Profit Margin	-153.8%	↑ 0.0%

	FY23	Y/Y Change
Revenue	$110.1M	↑ 0.0%
Net Income	$-169.4M	↑ 0.0%
Net Profit Margin	-153.8%	↑ 0.0%

	FY24	Y/Y Change
Revenue	$159.8M	↑ 7.13%
Net Income	$-45.4M	↓ 80.2%
Net Profit Margin	-28.43%	↑ 125.37%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$27.8M	↑ 0.0%
Net Income	$-20.0M	↑ 0.0%
Net Profit Margin	-71.95%	↑ 0.0%

	Q2 FY24	Q/Q Change
Revenue	$30.0M	↑ 9.12%
Net Income	$2.1M	↓ 110.41%
Net Profit Margin	6.86%	↑ 78.81%

	Q3 FY24	Q/Q Change
Revenue	$33.0M	↑ 8.86%
Net Income	$-4.0M	↓ 292.8%
Net Profit Margin	-12.15%	↓ 19.01%

	Q4 FY24	Q/Q Change
Revenue	$30.0M	↓ 4.4%
Net Income	$-16.1M	↑ 322.55%
Net Profit Margin	-53.73%	↓ 41.58%

	Q1 FY25	Q/Q Change
Revenue	$45.7M	↑ 53.52%
Net Income	$29.6M	↓ 284.94%
Net Profit Margin	64.72%	↑ 118.45%

	Q2 FY25	Q/Q Change
Revenue	$70.8M	↑ 7.91%
Net Income	$-6.3M	↓ 114.82%
Net Profit Margin	-8.89%	↓ 73.61%

FY21

FY22

FY23

FY24

	FY21	Y/Y Change
Profit	$-22.4M	-

	FY22	Y/Y Change
Profit	$23.8M	-

	FY23	Y/Y Change
Profit	$25.9M	-

	FY24	Y/Y Change
Profit	$47.5M	↑ 35.5%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$-670.7K	-

	Q2 FY24	Q/Q Change
Profit	$10.2M	↓ 1642.73%

	Q3 FY24	Q/Q Change
Profit	$12.7M	↑ 22.9%

	Q4 FY24	Q/Q Change
Profit	$9.7M	↓ 19.76%

	Q1 FY25	Q/Q Change
Profit	$12.8M	↑ 33.33%

	Q2 FY25	Q/Q Change
Profit	$26.1M	↑ 41.96%

FY21

FY22

FY23

FY24

	FY21	Y/Y Change
Operating Cash Flow	$-22.6M	↑ 0.0%
Investing Cash Flow	$-90.9M	↑ 0.0%
Financing Cash Flow	$137.7M	↑ 0.0%

	FY22	Y/Y Change
Operating Cash Flow	$-27.2M	↑ 0.0%
Investing Cash Flow	$33.1M	↑ 0.0%
Financing Cash Flow	$4.0M	↑ 0.0%

	FY22	Y/Y Change
Operating Cash Flow	$-27.2M	↑ 0.0%
Investing Cash Flow	$33.1M	↑ 0.0%
Financing Cash Flow	$4.0M	↑ 0.0%

	FY23	Y/Y Change
Operating Cash Flow	$-26.4M	↑ 1.72%
Investing Cash Flow	$3.4M	↑ 0.0%
Financing Cash Flow	$-556.7K	↓ 7.69%

	FY23	Y/Y Change
Operating Cash Flow	$-26.4M	↑ 1.72%
Investing Cash Flow	$3.4M	↑ 0.0%
Financing Cash Flow	$-556.7K	↓ 7.69%

	FY24	Y/Y Change
Operating Cash Flow	$2.9M	↓ 110.82%
Investing Cash Flow	$-28.6M	↓ 949.53%
Financing Cash Flow	$79.6M	↓ 14391.38%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-6.1M	↑ 0.0%
Investing Cash Flow	$-1.9M	-
Financing Cash Flow	$30.2M	↑ 0.0%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-2.7M	↓ 54.86%
Investing Cash Flow	$-10.9M	↑ 469.19%
Financing Cash Flow	$19.0M	↓ 36.24%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$6.6M	↓ 338.42%
Investing Cash Flow	$-16.5M	↑ 50.71%
Financing Cash Flow	$30.3M	↑ 57.4%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-2.9M	↓ 147.0%
Investing Cash Flow	$-43.2M	↑ 174.61%
Financing Cash Flow	$-141.6K	↓ 100.49%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-11.6M	↑ 296.77%
Investing Cash Flow	$-7.2M	↓ 83.27%
Financing Cash Flow	$28.3M	↓ 20228.71%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$14.6M	↓ 188.19%
Investing Cash Flow	$-9.4M	↓ 8.46%
Financing Cash Flow	$-560.0K	↓ 101.38%

Organigram Technicals Summary

Sell

Neutral

Buy

Organigram is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Organigram Holdings Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Organigram Holdings Inc	11.49%	42.24%	-9.84%	-62.84%	-67.77%
Haleon Plc Spon Ads	-0.77%	-5.64%	-3.46%	58.57%	29.89%
United Therapeutics Corporation	3.75%	-3.0%	-11.43%	42.23%	73.96%
Zoetis Inc.	2.71%	-6.16%	-14.98%	-1.93%	-3.23%
Neurocrine Biosciences Inc.	2.39%	16.43%	-10.25%	29.99%	19.76%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Organigram Holdings Inc	163.0	163.0	NA	0.05	-0.55	-0.06	NA	2.88
Haleon Plc Spon Ads	21.51	21.51	3.13	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	12.07	12.07	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.69	26.69	2.51	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	40.49	40.49	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Organigram Holdings Inc	Buy	$218.5M	-67.77%	163.0	3.47%
Haleon Plc Spon Ads	Buy	$43.9B	29.89%	21.51	13.81%
United Therapeutics Corporation	Buy	$14.0B	73.96%	12.07	40.36%
Zoetis Inc.	Buy	$68.6B	-3.23%	26.69	27.83%
Neurocrine Biosciences Inc.	Buy	$13.6B	19.76%	40.49	13.88%

About Organigram Holdings Inc

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Organization	Organigram
Employees	1178
CEO	Ms. Beena G. Goldenberg
Industry	Pharmaceuticals: Other

Key Management of Organigram Holdings Inc

Name	Title
Ms. Beena G. Goldenberg	CEO & Director
Mr. Greg Guyatt C.A., CPA	Chief Financial Officer
Ms. Helen Martin	Chief Legal Officer & Corporate Secretary
Mr. Timothy Emberg	President of Organigram Canada
Mr. Paolo De Luca C.A., C.F.A	Chief Strategy Officer
Ms. Nathalie Batten Kubrick	Executive Vice President of Operations
Max Schwartz	Director of Investor Relations
Ms. Katrina May McFadden	Chief People Officer
Mr. Gregory Engel	Special Advisor
Ms. Megan Amber McCrae	Senior VP of Corporate Strategy & International Growth

Important FAQs about investing in OGI Stock from India :

What is Organigram share price today?

Organigram share price today is $1.69 as on August 28, 2025 at 12:43 am IST. Organigram share today touched a day high of $1.69 and a low of $1.63.

What is the 52 week high and 52 week low for Organigram share?

Organigram share touched a 52 week high of $2.00 and a 52 week low of $0.85. Organigram stock price today i.e. August 28, 2025 at 12:43 am IST is trending at $1.69, lower by 15.5% versus the 52 week high.

How to invest in Organigram Stock (OGI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Organigram on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Organigram Shares that will get you 0.8876 shares as per Organigram share price of $1.69 per share as on August 28, 2025 at 12:43 am IST.

What is the minimum amount required to buy Organigram Stock (OGI) from India?

Indian investors can start investing in Organigram (OGI) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Organigram stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Organigram share’s latest price of $1.69 as on August 28, 2025 at 12:43 am IST, you will get 5.9172 shares of Organigram. Learn more about fractional shares .

What are the returns that Organigram has given to Indian investors in the last 5 years?

Organigram stock has given -67.77% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?